AFTER-GLP

Many people who use GLP‑1 medications (such as semaglutide or tirzepatide) achieve meaningful weight loss, but maintaining the weight loss after stopping the medication can be very challenging. Researchers at Tufts University are conducting a study to learn whether a digital lifestyle program can help people maintain their weight loss after they stop taking a GLP‑1 medication. Adults who have recently stopped a GLP‑1 medication may be eligible to participate. Participants will be randomly assigned to either receive access to a digital program or to continue with usual care. The study lasts 12 months and is fully remote. All participants will receive a Bluetooth scale to track weight from home and will complete short online questionnaires several times over the year. By taking part, you can help researchers better understand how to support long‑term weight maintenance in a way that is affordable, accessible, and sustainable. Participants are compensated up to $250 USD for their time if they complete all study activities, and your involvement may help improve care for others with similar experiences.